Chinese english Germany Japanese Korea

5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid

5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid Struktur
1417793-25-9
CAS-Nr.
1417793-25-9
Englisch Name:
5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid
Synonyma:
5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid;4-((1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)carbaMoyl)-1H-iMidazole-5-carboxylic acid;1H-Imidazole-5-carboxylic acid, 4-[[[1-[(1,1-dimethylethoxy)carbonyl]-3-pyrrolidinyl]amino]carbonyl]-
CBNumber:
CB62659307
Summenformel:
C14H20N4O5
Molgewicht:
324.33
MOL-Datei:
1417793-25-9.mol
Request For Quotation

5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid Eigenschaften

Siedepunkt:
629.1±55.0 °C(Predicted)
Dichte
1.38±0.1 g/cm3(Predicted)
pka
11.94±0.10(Predicted)

Sicherheit

5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Amadis Chemical Company Limited 		571-89925085
sales@amadischem.com China 131980 58
Meryer (Shanghai) Chemical Technology Co., Ltd. 021-61259108 18621169109
 market03@meryer.com China 40240 62
BePharm Ltd 400-685-9117
market@bepharm.com China 15081 60
  • 5-(1-tert-Butoxycarbonyl-pyrrolidin-3-ylcarbaMoyl)-3H-iMidazole-4-carboxylic acid
  • 4-((1-(tert-Butoxycarbonyl)pyrrolidin-3-yl)carbaMoyl)-1H-iMidazole-5-carboxylic acid
  • 1H-Imidazole-5-carboxylic acid, 4-[[[1-[(1,1-dimethylethoxy)carbonyl]-3-pyrrolidinyl]amino]carbonyl]-
  • 1417793-25-9
Copyright 2019 © ChemicalBook. All rights reserved